Literature DB >> 21236490

The emergence of ADAM10 as a regulator of lymphocyte development and autoimmunity.

David R Gibb1, Sheinei J Saleem, Natalia S Chaimowitz, Joel Mathews, Daniel H Conrad.   

Abstract

Proteolytic processing of transmembrane receptors and ligands can have a dramatic impact on cell signaling processes and subsequent cellular responses, including activation and differentiation. A member of the disintegrin and metalloproteinase family, ADAM10, has emerged as a prominent regulator of numerous receptors and ligands, including Notch and CD23. Here, we review studies resulting from the recent generation of ADAM10 conditional knockout mice which revealed a critical role for ADAM10 in Notch-dependent lymphocyte development. Additionally, we discuss results of numerous in vitro and ex vivo studies indicating that ADAM10 regulates the production of multiple secreted factors that contribute to autoimmune reactions.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21236490      PMCID: PMC3083477          DOI: 10.1016/j.molimm.2010.12.005

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  116 in total

1.  Role of LAG-3 in regulatory T cells.

Authors:  Ching-Tai Huang; Creg J Workman; Dallas Flies; Xiaoyu Pan; Aimee L Marson; Gang Zhou; Edward L Hipkiss; Sowmya Ravi; Jeanne Kowalski; Hyam I Levitsky; Jonathan D Powell; Drew M Pardoll; Charles G Drake; Dario A A Vignali
Journal:  Immunity       Date:  2004-10       Impact factor: 31.745

2.  Lymphocyte activation gene-3 (CD223) regulates the size of the expanding T cell population following antigen activation in vivo.

Authors:  Creg J Workman; Linda S Cauley; In-Jeong Kim; Marcia A Blackman; David L Woodland; Dario A A Vignali
Journal:  J Immunol       Date:  2004-05-01       Impact factor: 5.422

3.  A disintegrin and metalloproteinase 10-mediated cleavage and shedding regulates the cell surface expression of CXC chemokine ligand 16.

Authors:  Peter J Gough; Kyle J Garton; Paul T Wille; Marcin Rychlewski; Peter J Dempsey; Elaine W Raines
Journal:  J Immunol       Date:  2004-03-15       Impact factor: 5.422

4.  Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis.

Authors:  R Watanabe-Fukunaga; C I Brannan; N G Copeland; N A Jenkins; S Nagata
Journal:  Nature       Date:  1992-03-26       Impact factor: 49.962

5.  Notch1 is essential for postimplantation development in mice.

Authors:  P J Swiatek; C E Lindsell; F F del Amo; G Weinmaster; T Gridley
Journal:  Genes Dev       Date:  1994-03-15       Impact factor: 11.361

6.  Myeloproliferative disease in mice with reduced presenilin gene dosage: effect of gamma-secretase blockage.

Authors:  Yibing Qyang; Stuart M Chambers; Pei Wang; Xuefeng Xia; Xiaoli Chen; Margaret A Goodell; Hui Zheng
Journal:  Biochemistry       Date:  2004-05-11       Impact factor: 3.162

7.  The transmembrane CXC-chemokine ligand 16 is induced by IFN-gamma and TNF-alpha and shed by the activity of the disintegrin-like metalloproteinase ADAM10.

Authors:  Soeren Abel; Christian Hundhausen; Rolf Mentlein; Alexander Schulte; Theo A Berkhout; Neil Broadway; Dieter Hartmann; Radek Sedlacek; Sebastian Dietrich; Barbara Muetze; Bjoern Schuster; Karl-Josef Kallen; Paul Saftig; Stefan Rose-John; Andreas Ludwig
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

8.  Selective roles for tumor necrosis factor alpha-converting enzyme/ADAM17 in the shedding of the epidermal growth factor receptor ligand family: the juxtamembrane stalk determines cleavage efficiency.

Authors:  C Leann Hinkle; Susan W Sunnarborg; David Loiselle; Carol E Parker; Mary Stevenson; William E Russell; David C Lee
Journal:  J Biol Chem       Date:  2004-04-05       Impact factor: 5.157

9.  Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand.

Authors:  T Takahashi; M Tanaka; C I Brannan; N A Jenkins; N G Copeland; T Suda; S Nagata
Journal:  Cell       Date:  1994-03-25       Impact factor: 41.582

10.  Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands.

Authors:  Umut Sahin; Gisela Weskamp; Kristine Kelly; Hong-Ming Zhou; Shigeki Higashiyama; Jacques Peschon; Dieter Hartmann; Paul Saftig; Carl P Blobel
Journal:  J Cell Biol       Date:  2004-03-01       Impact factor: 10.539

View more
  17 in total

Review 1.  Regulation of α-secretase ADAM10 expression and activity.

Authors:  Kristina Endres; Falk Fahrenholz
Journal:  Exp Brain Res       Date:  2011-10-04       Impact factor: 1.972

2.  ADAM10 is required for SCF-induced mast cell migration.

Authors:  Travis W Faber; Nicholas A Pullen; Josephine F A Fernando; Elizabeth Motunrayo Kolawole; Jamie J A McLeod; Marcela Taruselli; Kathryn L Williams; Kevin O Rivera; Brian O Barnstein; Daniel H Conrad; John J Ryan
Journal:  Cell Immunol       Date:  2014-05-21       Impact factor: 4.868

3.  A disintegrin and metalloproteinase 10 regulates antibody production and maintenance of lymphoid architecture.

Authors:  Natalia S Chaimowitz; Rebecca K Martin; Joanna Cichy; David R Gibb; Pooja Patil; Dae-Joong Kang; Julie Farnsworth; Eugene C Butcher; Brent McCright; Daniel H Conrad
Journal:  J Immunol       Date:  2011-10-12       Impact factor: 5.422

4.  Soluble T cell immunoglobulin mucin domain 3 is shed from CD8+ T cells by the sheddase ADAM10, is increased in plasma during untreated HIV infection, and correlates with HIV disease progression.

Authors:  Kiera L Clayton; Matthew B Douglas-Vail; A K M Nur-ur Rahman; Karyn E Medcalf; Irene Y Xie; Glen M Chew; Ravi Tandon; Marion C Lanteri; Philip J Norris; Steven G Deeks; Lishomwa C Ndhlovu; Mario A Ostrowski
Journal:  J Virol       Date:  2015-01-21       Impact factor: 5.103

5.  Identification of genes expressed in the migrating primitive myeloid lineage of Xenopus laevis.

Authors:  Zachary N Agricola; Amrita K Jagpal; Andrew W Allbee; Allison R Prewitt; Emily T Shifley; Scott A Rankin; Aaron M Zorn; Alan P Kenny
Journal:  Dev Dyn       Date:  2015-11-20       Impact factor: 3.780

Review 6.  The ADAMs family of proteases as targets for the treatment of cancer.

Authors:  Maeve Mullooly; Patricia M McGowan; John Crown; Michael J Duffy
Journal:  Cancer Biol Ther       Date:  2016-04-26       Impact factor: 4.742

7.  ADAM10 is the major sheddase responsible for the release of membrane-associated meprin A.

Authors:  Christian Herzog; Randy S Haun; Andreas Ludwig; Sudhir V Shah; Gur P Kaushal
Journal:  J Biol Chem       Date:  2014-03-24       Impact factor: 5.157

8.  ADAM10 regulates transcription factor expression required for plasma cell function.

Authors:  Natalia S Chaimowitz; Dae-Joong Kang; Lee M Dean; Daniel H Conrad
Journal:  PLoS One       Date:  2012-08-03       Impact factor: 3.240

9.  Metalloproteinase-dependent TLR2 ectodomain shedding is involved in soluble toll-like receptor 2 (sTLR2) production.

Authors:  Patricia Langjahr; David Díaz-Jiménez; Marjorie De la Fuente; Estefhany Rubio; Douglas Golenbock; Francisca C Bronfman; Rodrigo Quera; María-Julieta González; Marcela A Hermoso
Journal:  PLoS One       Date:  2014-12-22       Impact factor: 3.240

10.  A CD21 low phenotype, with no evidence of autoantibodies to complement proteins, is consistent with a poor prognosis in CLL.

Authors:  Eva-Maria Nichols; Rachel Jones; Rachael Watson; Chris J Pepper; Chris Fegan; Kevin J Marchbank
Journal:  Oncotarget       Date:  2015-10-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.